Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection
Jin Wei,Mia Madel Alfajaro,Peter C DeWeirdt,Ruth E Hanna,William J Lu-Culligan,Wesley L Cai,Madison S Strine,Shang-Min Zhang,Vincent R Graziano,Cameron O Schmitz,Jennifer S Chen,Madeleine C Mankowski,Renata B Filler,Neal G Ravindra,Victor Gasque,Fernando J de Miguel,Ajinkya Patil,Huacui Chen,Kasopefoluwa Y Oguntuyo,Laura Abriola,Yulia V Surovtseva,Robert C Orchard,Benhur Lee,Brett D Lindenbach,Katerina Politi,David van Dijk,Cigall Kadoch,Matthew D Simon,Qin Yan,John G Doench,Craig B Wilen
DOI: https://doi.org/10.1016/j.cell.2020.10.028
IF: 64.5
2021-01-07
Cell
Abstract:Identification of host genes essential for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may reveal novel therapeutic targets and inform our understanding of coronavirus disease 2019 (COVID-19) pathogenesis. Here we performed genome-wide CRISPR screens in Vero-E6 cells with SARS-CoV-2, Middle East respiratory syndrome CoV (MERS-CoV), bat CoV HKU5 expressing the SARS-CoV-1 spike, and vesicular stomatitis virus (VSV) expressing the SARS-CoV-2 spike. We identified known SARS-CoV-2 host factors, including the receptor ACE2 and protease Cathepsin L. We additionally discovered pro-viral genes and pathways, including HMGB1 and the SWI/SNF chromatin remodeling complex, that are SARS lineage and pan-coronavirus specific, respectively. We show that HMGB1 regulates ACE2 expression and is critical for entry of SARS-CoV-2, SARS-CoV-1, and NL63. We also show that small-molecule antagonists of identified gene products inhibited SARS-CoV-2 infection in monkey and human cells, demonstrating the conserved role of these genetic hits across species. This identifies potential therapeutic targets for SARS-CoV-2 and reveals SARS lineage-specific and pan-CoV host factors that regulate susceptibility to highly pathogenic CoVs.